Ketamine Infusions for PTSD and Treatment-Resistant Depression
Efficacy and Safety of Repeated Intravenous Subanesthetic Ketamine Infusions Among Veterans With Treatment Resistant Depression Comorbid With Chronic Post-Traumatic Stress Disorder: A Proof-of-concept Study
Sponsor: Minneapolis Veterans Affairs Medical Center
A PHASE1 clinical study on Depressive Disorder, Treatment-Resistant and Stress Disorders, Post-Traumatic, this trial is completed. The trial is conducted by Minneapolis Veterans Affairs Medical Center and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2019 — Jan 2021 [monthly]
Completed PHASE1
Status: Unknown Status → Completed
-
Jun 2018 — Jun 2019 [monthly]
Unknown Status PHASE1
▶ Show 3 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Feb 2017 — Oct 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Minneapolis Veterans Affairs Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .